G P Canellos, S E Come, A T Skarin. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Antineoplastic Agents/administration & dosageAntineoplastic Agents/adverse effectsAntineoplastic Combined Chemotherapy ProtocolsBleomycin/administration & dosageBleomycin/adverse effectsDacarbazine/administration & dosageDacarbazine/adverse effectsDoxorubicin/administration & dosageDoxorubicin/adverse effectsDrug Therapy, CombinationHodgkin Disease/drug therapyHumansMechlorethamine/administration & dosageMechlorethamine/adverse effectsPrednisone/administration & dosagePrednisone/adverse effectsProcarbazine/administration & dosageProcarbazine/adverse effectsVinblastineVincristine/administration & dosageVincristine/adverse effects
Substances: See more » Antineoplastic AgentsBleomycinProcarbazineMechlorethamineVincristineVinblastineDacarbazineDoxorubicinPrednisone
Year: 1983 PMID: 6189191
Source DB: PubMed Journal: Semin Hematol ISSN: 0037-1963 Impact factor: 3.851